对儿童和青少年喘的心理干预措施
Kelsey J Sharrad1, Olatokunbo Sanwo2, Sofia Cuevas-Asturias3
1Allied Health & Human Performance, University of South Australia, Adelaide, Australia.
The Cochrane database of systematic reviews
|January 11, 2024
概括
心理干预对患有喘的儿童有潜在的益处,改善焦虑,抑郁和药物坚持. 然而,证据质量非常不确定,需要进一步研究以标准化结果.
科学领域:
- 儿科肺病学 儿科肺病学
- 行为医学是一种行为医学.
- 临床心理学 临床心理学
背景情况:
- 儿童喘很普遍,并与较差的健康结果有关.
- 患有喘的儿童面临着独特的心理困扰,以及发展上的挑战.
- 心理干预可以提高自我效能和药物坚持,减少喘恶化.
研究的目的:
- 为了评估心理干预在患有喘的儿童的有效性.
- 为了比较心理干预与通常的护理或没有治疗.
- 评估儿童喘患者对健康和行为结果的影响.
主要方法:
- 随机对照试验 (RCT) 的系统审查和叙事合成.
- 包括患有喘的儿童和青少年 (5-18岁).
- 搜索主要数据库至2022年8月,包括24项研究.
主要成果:
- 大多数研究表明,心理干预对焦虑,抑郁,喘症状和药物使用有积极影响.
- 减少医疗接触和改善生活质量的证据有限.
- 由于异质性和偏差风险,证据的确定性在所有结果中都非常低.
结论:
- 心理干预有希望,但证据非常不确定.
- 由于异质性和报告问题,很难评估临床意义.
- 对于未来关于儿童喘心理干预的研究,需要标准化结果.
相关概念视频
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma-IV: Nursing Management
3.1K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.1K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
299
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
299
Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K
Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K


